Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
293M
-
Shares change
-
+16.4M
-
Total reported value, excl. options
-
$2.8B
-
Value change
-
+$155M
-
Put/Call ratio
-
0.69
-
Number of buys
-
105
-
Number of sells
-
-97
-
Price
-
$9.55
Significant Holders of Amicus Therapeutics Inc - Common Stock (FOLD) as of Q3 2021
276 filings reported holding FOLD - Amicus Therapeutics Inc - Common Stock as of Q3 2021.
Amicus Therapeutics Inc - Common Stock (FOLD) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 293M shares
of 309M outstanding shares and own 94.78% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (26.6M shares), VANGUARD GROUP INC (24.5M shares), WELLINGTON MANAGEMENT GROUP LLP (24.3M shares), Redmile Group, LLC (20.8M shares), BlackRock Inc. (19.6M shares), Avoro Capital Advisors LLC (17.7M shares), JPMORGAN CHASE & CO (15.3M shares), MORGAN STANLEY (11.7M shares), Palo Alto Investors LP (10.1M shares), and STATE STREET CORP (10M shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.